# Priming of the NEonatal Immune System by Transfer of Maternal Immunity

> **NCT05429047** · — · UNKNOWN · sponsor: **Hannover Medical School** · enrollment: 560 (estimated)

## Conditions studied

- COVID-19
- Maternal Vaccine Exposure
- Respiratory Infections in Children

## Interventions

- **BIOLOGICAL:** Tozinameran
- **OTHER:** COVID-19
- **OTHER:** No SARS-CoV-2 exposure

## Key facts

- **NCT ID:** NCT05429047
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-07
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429047, "Priming of the NEonatal Immune System by Transfer of Maternal Immunity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05429047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*